• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有或无早产儿视网膜病变的早产儿在3个月至5岁半之间的近视患病率。早产儿视网膜病变冷冻治疗协作组。

Prevalence of myopia between 3 months and 5 1/2 years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.

作者信息

Quinn G E, Dobson V, Kivlin J, Kaufman L M, Repka M X, Reynolds J D, Gordon R A, Hardy R J, Tung B, Stone R A

机构信息

Division of Pediatric Ophthalmology, Children's Hospital of Philadelphia, PA 19104, USA.

出版信息

Ophthalmology. 1998 Jul;105(7):1292-300. doi: 10.1016/s0161-6420(98)97036-1.

DOI:10.1016/s0161-6420(98)97036-1
PMID:9663236
Abstract

PURPOSE

The purpose of the study was to examine spherical equivalent refractive errors, especially myopia, at six ages between 3 months and 5 1/2 years post-term in preterm children with birth weights of less than 1251 g.

DESIGN

A cohort study.

PARTICIPANTS

There were a total of 827 participants in the multicenter study of cryotherapy for retinopathy of prematurity (ROP). Approximately one third of the eyes did not develop ROP, whereas two thirds developed mild-to-severe ROP. None of the eyes underwent cryotherapy.

INTERVENTION

Refractive error was measured at 3 months, 1 year, and 5 1/2 years term due date at the five long-term follow-up centers. In most eyes, refractive error also was measured at 2, 3 1/2, and 4 1/2 years.

MAIN OUTCOME MEASURE

Myopia was defined as 0.25 diopter (D) or greater with high myopia as 5 D or greater.

RESULTS

The proportion of eyes with myopia in this preterm population was increased compared to published data on full-term children and was related to severity of both acute-phase and cicatricial-phase ROP. The percentage of eyes with myopia varied little across ages, ranging from 21.2% at 1 year to 15.7% at 4 1/2 years. The percentage of eyes with high myopia doubled from 1.8% to 3.9% between 3 months and 1 year and remained stable thereafter. The distribution of refractive errors in eyes with mild acute-phase ROP was similar to that of eyes with no ROP. In contrast, eyes with moderate or severe acute-phase ROP showed an increased prevalence of high myopia. The distribution of refractive errors changed between 3 months and 1 year with little change after 1 year. This pattern of refractive development differs from that of full-term infants. Birth weight, severity of ROP, and degree of myopia at 3 months predicted the presence of myopia and high myopia at 5 1/2 years of age.

CONCLUSIONS

The distribution of refractive errors in preterm infants from age 3 months to 5 1/2 years varies with severity of acute-phase ROP and cicatricial disease. Changes in refractive error distribution occur primarily between 3 months and 1 year and involve a decrease in the proportion of eyes with hyperopia and an increase in the proportion with high degrees of myopia.

摘要

目的

本研究旨在调查出生体重低于1251克的早产儿在足月后3个月至5岁半这六个年龄段的等效球镜屈光不正情况,尤其是近视情况。

设计

队列研究。

参与者

共有827名参与者参加了早产儿视网膜病变(ROP)冷冻治疗的多中心研究。约三分之一的眼睛未发生ROP,而三分之二的眼睛发生了轻度至重度ROP。所有眼睛均未接受冷冻治疗。

干预

在五个长期随访中心于足月后3个月、1岁和5岁半测量屈光不正。在大多数眼睛中,还于2岁、3岁半和4岁半测量了屈光不正。

主要观察指标

近视定义为屈光度为0.25D或更高,高度近视为5D或更高。

结果

与足月儿的已发表数据相比,该早产儿群体中近视眼睛的比例有所增加,且与急性期和瘢痕期ROP的严重程度相关。近视眼睛的百分比在各年龄段变化不大,从1岁时的21.2%到4岁半时的15.7%。高度近视眼睛的百分比在3个月至1岁之间从1.8%翻倍至3.9%,此后保持稳定。轻度急性期ROP眼睛的屈光不正分布与无ROP眼睛相似。相比之下,中度或重度急性期ROP眼睛的高度近视患病率增加。屈光不正分布在3个月至1岁之间发生变化,1岁后变化不大。这种屈光发育模式与足月儿不同。出生体重、ROP严重程度和3个月时的近视度数可预测5岁半时近视和高度近视的存在。

结论

3个月至5岁半的早产儿屈光不正分布随急性期ROP和瘢痕期疾病的严重程度而变化。屈光不正分布的变化主要发生在3个月至1岁之间,包括远视眼睛比例的下降和高度近视眼睛比例的增加。

相似文献

1
Prevalence of myopia between 3 months and 5 1/2 years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.有或无早产儿视网膜病变的早产儿在3个月至5岁半之间的近视患病率。早产儿视网膜病变冷冻治疗协作组。
Ophthalmology. 1998 Jul;105(7):1292-300. doi: 10.1016/s0161-6420(98)97036-1.
2
Does cryotherapy affect refractive error? Results from treated versus control eyes in the cryotherapy for retinopathy of prematurity trial.冷冻疗法会影响屈光不正吗?早产儿视网膜病变冷冻治疗试验中治疗眼与对照眼的结果。
Ophthalmology. 2001 Feb;108(2):343-7. doi: 10.1016/s0161-6420(00)00527-3.
3
Development of myopia in infants with birth weights less than 1251 grams. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.出生体重低于1251克婴儿的近视发展。早产儿视网膜病变冷冻治疗协作组。
Ophthalmology. 1992 Mar;99(3):329-40. doi: 10.1016/s0161-6420(92)31968-2.
4
Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings to 3 years of age.早产儿视网膜病变早期治疗研究中近视和高度近视的进展:至3岁时的研究结果
Ophthalmology. 2008 Jun;115(6):1058-1064.e1. doi: 10.1016/j.ophtha.2007.07.028.
5
Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity.阈值前早产儿视网膜病变高危婴儿9个月时的近视患病率。
Ophthalmology. 2005 Sep;112(9):1564-8. doi: 10.1016/j.ophtha.2005.03.025.
6
Myopia in premature infants at the age of 6 months.6个月大早产儿的近视
Korean J Ophthalmol. 1992 Jun;6(1):44-9. doi: 10.3341/kjo.1992.6.1.44.
7
Refractive outcome of premature infants with or without retinopathy of prematurity at 2 years of age: a prospective controlled cohort study.早产儿有无早产儿视网膜病变 2 年时的屈光结果:前瞻性对照队列研究。
Kaohsiung J Med Sci. 2012 Apr;28(4):204-11. doi: 10.1016/j.kjms.2011.10.010. Epub 2012 Feb 12.
8
Long term refractive outcome in eyes of preterm infants with and without retinopathy of prematurity: comparison of keratometric value, axial length, anterior chamber depth, and lens thickness.有和没有早产儿视网膜病变的早产儿眼睛的长期屈光结果:角膜曲率值、眼轴长度、前房深度和晶状体厚度的比较。
Br J Ophthalmol. 2000 Feb;84(2):138-43. doi: 10.1136/bjo.84.2.138.
9
Multicenter trial of cryotherapy for retinopathy of prematurity: natural history ROP: ocular outcome at 5(1/2) years in premature infants with birth weights less than 1251 g.早产儿视网膜病变冷冻疗法的多中心试验:早产儿视网膜病变自然病史:出生体重小于1251克的早产儿5.5岁时的眼部结局
Arch Ophthalmol. 2002 May;120(5):595-9. doi: 10.1001/archopht.120.5.595.
10
Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of age.早产儿视网膜病变早期治疗研究中近视和高度近视的进展:4至6岁时的研究结果
J AAPOS. 2013 Apr;17(2):124-8. doi: 10.1016/j.jaapos.2012.10.025.

引用本文的文献

1
Incidence and Prevalence of Retinopathy of Prematurity in a Tertiary Care Centre of North India.印度北部一家三级医疗中心早产儿视网膜病变的发病率和患病率
Maedica (Bucur). 2023 Jun;18(2):232-237. doi: 10.26574/maedica.2023.18.2.232.
2
IMI-Management and Investigation of High Myopia in Infants and Young Children.婴儿和幼儿高度近视的管理和调查。
Invest Ophthalmol Vis Sci. 2023 May 1;64(6):3. doi: 10.1167/iovs.64.6.3.
3
Association between myopia progression and quantity of laser treatment for retinopathy of prematurity.近视进展与早产儿视网膜病变激光治疗量的关系。
PLoS One. 2022 Dec 30;17(12):e0279898. doi: 10.1371/journal.pone.0279898. eCollection 2022.
4
Ophthalmic complications in retinopathy of prematurity in the first decade of life in Korea using the national health insurance database.韩国使用国家健康保险数据库研究生命最初十年中早产儿视网膜病变的眼部并发症。
Sci Rep. 2022 Jan 18;12(1):911. doi: 10.1038/s41598-021-04616-7.
5
Longitudinal Development of Refractive Error in Children Treated With Intravitreal Bevacizumab or Laser for Retinopathy of Prematurity.早产儿视网膜病变患儿接受玻璃体内注射贝伐单抗或激光治疗后的屈光不正纵向发展。
Transl Vis Sci Technol. 2021 Apr 1;10(4):14. doi: 10.1167/tvst.10.4.14.
6
The Long-Term Effect of Medically Enhancing Melanin Intrinsic Bioenergetics Capacity in Prematurity.医学增强早产中黑色素内在生物能量学能力的长期影响。
Curr Genomics. 2020 Nov;21(7):525-530. doi: 10.2174/1389202921999200417172817.
7
The relationship of ocular geometry with refractive error in normal and low birth weight adults.正常出生体重和低出生体重成年人的眼几何形状与屈光不正的关系。
J Optom. 2021 Jan-Mar;14(1):50-57. doi: 10.1016/j.optom.2020.08.004. Epub 2020 Sep 23.
8
Development of refractive error in children treated for retinopathy of prematurity with anti-vascular endothelial growth factor (anti-VEGF) agents: A meta-analysis and systematic review.早产儿视网膜病变患儿接受抗血管内皮生长因子(anti-VEGF)药物治疗后屈光不正的发展:一项荟萃分析和系统评价。
PLoS One. 2019 Dec 2;14(12):e0225643. doi: 10.1371/journal.pone.0225643. eCollection 2019.
9
Refractive Outcomes of 4-Year-old Children after Intravitreal Anti-vascular Endothelial Growth Factor versus Laser Photocoagulation for Retinopathy of Prematurity.玻璃体内注射抗血管内皮生长因子与激光光凝治疗早产儿视网膜病变后4岁儿童的屈光结局
Korean J Ophthalmol. 2019 Jun;33(3):272-278. doi: 10.3341/kjo.2019.0011.
10
Comparison of intravitreal bevacizumab injection and laser photocoagulation for type 1 zone II retinopathy of prematurity.玻璃体内注射贝伐单抗与激光光凝治疗1型二区早产儿视网膜病变的比较。
J Curr Ophthalmol. 2018 Nov 9;31(1):61-65. doi: 10.1016/j.joco.2018.10.008. eCollection 2019 Mar.